Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sensei Biotherapeutics, Inc.

0.4570
+0.01703.86%
Post-market: 0.46000.0030+0.66%16:25 EDT
Volume:26.04K
Turnover:11.81K
Market Cap:11.49M
PE:-0.38
High:0.4700
Open:0.4650
Low:0.4403
Close:0.4400
Loading ...

Sensei Biotherapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
24 Feb

What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock

Zacks
·
07 Feb

Sensei Biotherapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
04 Feb

Sensei Biotherapeutics Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Jan

BRIEF-Sensei Biotherapeutics Provides Corporate Update And Highlights Key Upcoming Milestones

Reuters
·
08 Jan

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

THOMSON REUTERS
·
08 Jan

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

GlobeNewswire
·
08 Jan

Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference

GlobeNewswire
·
28 Nov 2024

Sensei Biotherapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024

Sensei Biotherapeutics reports Q3 EPS (29c), consensus (32c)

TIPRANKS
·
14 Nov 2024

Sensei Biotherapeutics Inc: Cash Runway Extended Into Q2 of 2026

THOMSON REUTERS
·
14 Nov 2024

Sensei Biotherapeutics Q3 Income From Operations USD -7.823 Million

THOMSON REUTERS
·
14 Nov 2024

Sensei Biotherapeutics Q3 Basic EPS USD -0.29

THOMSON REUTERS
·
14 Nov 2024

Press Release: Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Dow Jones
·
14 Nov 2024

Sensei Biotherapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
01 Nov 2024

Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences

GlobeNewswire
·
29 Oct 2024